- Trials with a EudraCT protocol (58)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
58 result(s) found for: Entecavir.
Displaying page 1 of 3.
EudraCT Number: 2008-005976-28 | Sponsor Protocol Number: ETV-after-HBV-related-LTx | Start Date*: 2009-08-19 | |||||||||||
Sponsor Name:Hannover Medical School | |||||||||||||
Full Title: Prevention of HBV reinfection after liver transplantation using entecavir monotherapy after short-term HBIg administration: A pilot study Version 1.2 2008-09-11 Amendment 2 2009-07-07 | |||||||||||||
Medical condition: chronic hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000453-22 | Sponsor Protocol Number: AI463-109 | Start Date*: 2007-03-08 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection. Revised Protocol 01, incorporating Amendment 02 (Version 1.0 Date 20... | |||||||||||||
Medical condition: CHRONIC HEPATITIS B VIRUS,TRANSPLANT | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016357-17 | Sponsor Protocol Number: AI463-189 | Start Date*: 2010-12-20 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) versus Placebo in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are HBeAg-Positive Revised Pro... | |||||||||||||
Medical condition: CHRONIC HEPATITIS B VIRUS,PEDIATRIC | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) GR (Completed) BE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004272-11 | Sponsor Protocol Number: 2B | Start Date*: 2011-11-30 |
Sponsor Name:Erasmus MC | ||
Full Title: The BOKITO-2B Study: Tenofovir DF Bone and Kidney Toxicity. Incidence and reversibility in HBV-monoinfected patients. | ||
Medical condition: Chronic hepatitis B | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007296-24 | Sponsor Protocol Number: 08/01 | Start Date*: 2009-01-21 | |||||||||||
Sponsor Name:AISF - ASSOCIAZIONE ITALIANA PER LO STUDIO DEL FEGATO | |||||||||||||
Full Title: Multicenter open-label, phase IIB study with 0.5 mg / day Entecavir (BARACLUDE ) in patients with positive HBsAg solid or hematologic malignancies undergoing chemotherapy (ChemET) (ChemET) | |||||||||||||
Medical condition: Subject with new diagnosis of solid or haematological cancer in inactive carrier in chronic virus B infected patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004751-31 | Sponsor Protocol Number: Heparc-2003 | Start Date*: 2015-06-26 | |||||||||||
Sponsor Name:Arrowhead Research Corporation | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Multi-dose Study to Determine the Depth of Hepatitis B Surface Antigen (HBsAg) Reduction Following Intravenous ARC-520 in Combination wi... | |||||||||||||
Medical condition: Chronic Hepatitis B Virus Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019884-12 | Sponsor Protocol Number: INFIRE-001 | Start Date*: 2010-12-17 | |||||||||||
Sponsor Name:Universitätsklinikum Aachen | |||||||||||||
Full Title: Induction of Fibrosis Regression regarding Chronic Hepatitis B Infection | |||||||||||||
Medical condition: Patients with chronic hepatitis B infection and a relevant grade of fibrosis (histological >= F2) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000977-31 | Sponsor Protocol Number: NV25361 | Start Date*: 2006-05-05 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: PHASE IIIB, RANDOMIZED, OPEN LABEL STUDY OF PEGYLATED INTERFERON ALFA-2A IN COMBINATION WITH LAMIVUDINE OR ENTECAVIR COMPARED WITH UNTREATED CONTROL PATIENTS IN CHILDREN WITH HBEAG POSITIVE CHRONIC... | |||||||||||||
Medical condition: Chronic Hepatitis B Virus infection | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000724-34 | Sponsor Protocol Number: Nuc-STOP | Start Date*: 2018-07-02 | |||||||||||
Sponsor Name:Oslo University Hospital HF | |||||||||||||
Full Title: Norwegian Nucleoside Analogue Stop Study (Nuc-STOP) - A randomized open-label trial in HBeAg negative chronic hepatitis B, aiming at achieving a functional Cure | |||||||||||||
Medical condition: HBeAg negative chronic hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) SE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004145-27 | Sponsor Protocol Number: Heparc-2002 | Start Date*: 2015-06-26 | |||||||||||
Sponsor Name:Arrowhead Pharmaceuticals Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Multi-dose Study to Determine the Depth of Hepatitis B Surface Antigen (HBsAg) Reduction Following Intravenous ARC-520 in Combination wi... | |||||||||||||
Medical condition: Chronic Hepatitis B Virus Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006239-11 | Sponsor Protocol Number: HBV 09-01 | Start Date*: 2009-05-15 | |||||||||||
Sponsor Name:Stichting Lever Onderzoek | |||||||||||||
Full Title: Augmenting response to entecavir using a temporary peginterferon alpha-2a add-on strategy for the treatment of HBeAg-positive chronic hepatitis B (ARES study) | |||||||||||||
Medical condition: Chronic hepatitis B virus infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002042-36 | Sponsor Protocol Number: ABI-H0731-202 | Start Date*: 2018-08-06 |
Sponsor Name:Assembly Biosciences | ||
Full Title: A Phase 2a, Multi-center, Double-blind, Placebo-controlled Study Evaluating ABI-H0731 + Entecavir vs Entecavir Alone for the Treatment of Viremic, HBeAg-positive Patients with Chronic Hepatitis B | ||
Medical condition: Chronic Hepatitis B | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-015705-40 | Sponsor Protocol Number: AI463203 | Start Date*: 2010-04-08 | |||||||||||
Sponsor Name:Bristol Myers Squibb International Corporation | |||||||||||||
Full Title: Protocol AI463203: A Study of the Safety and Efficacy of Entecavir plus Tenofovir in Adults with Chronic Hepatitis B Virus Infection with Previous Nucleoside/Nucleotide Treatment Failure | |||||||||||||
Medical condition: Chronic Hepatitis B Virus Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) IT (Completed) DE (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001003-32 | Sponsor Protocol Number: 1 | Start Date*: 2021-07-28 |
Sponsor Name:Antwerp University Hospital | ||
Full Title: Controlled Interruption of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Infections | ||
Medical condition: Chronic Hepatitis B Infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000422-31 | Sponsor Protocol Number: AI 463-111 | Start Date*: 2007-07-06 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: Comparative Study of Entecavir vs Adefovir vs the Combination in Lamivudine- Refractory Chronic Hepatitis B Subjects The DEFINE Study Revised Protocol 01 | |||||||||||||
Medical condition: CHRONIC HEPATITIS B VIRUS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004096-37 | Sponsor Protocol Number: GS-US-174-0108 | Start Date*: 2006-05-19 | |||||||||||
Sponsor Name:Gilead Sciences Incorporated | |||||||||||||
Full Title: A Phase 2, Double-Blind, Multi-center, Randomized Study Comparing Tenofovir Disoproxil Fumarate, Emtricitabine Plus Tenofovir Disoproxil Fumarate, and Entecavir in the Treatment of Chronic Hepatiti... | |||||||||||||
Medical condition: Chronic Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) ES (Completed) GB (Completed) DE (Completed) IT (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003284-22 | Sponsor Protocol Number: AI463080 | Start Date*: 2007-03-19 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated with Nucleoside/Nucleotide Monotherapy for Patients with Chronic HBV Infection: The REALM Study | |||||||||||||
Medical condition: CHRONIC HEPATITIS B VIRUS INFECTION | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) ES (Completed) IT (Completed) PT (Completed) GR (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005816-26 | Sponsor Protocol Number: AI463-028 | Start Date*: 2007-08-30 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are HBeAg-Positive. Revised Pro... | |||||||||||||
Medical condition: Chronic Hepatitis B Virus (HBV) Infection | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018523-26 | Sponsor Protocol Number: AOBSMI2ENT001-010 | Start Date*: 2010-03-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: Immediate versus delayed treatment with Entecavir in patients with active chronic hepatitis B (CHB): impact on liver fibrosis. | |||||||||||||
Medical condition: Patients with chronic HBV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003894-41 | Sponsor Protocol Number: ImmunoPeg | Start Date*: 2014-11-21 | |||||||||||
Sponsor Name:Azienda Ospedaliero-Universitaria di Parma | |||||||||||||
Full Title: Effect of a Peg-interferon alfa 2A pulse on HBV-specific T cell responses in chronic hepatitis HBeAg negative patients under long-term nucleos(t)ide treatment | |||||||||||||
Medical condition: Chronic hepatitis B infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
